BDX BD Company Net Income

BDX (Becton Dickinson) - company brandmark

How do digital alliances and mergers of Becton Dickinson & Co (BDX) impact financial results? The company's final net income on this chart provides the answer, where 0.94 reflects the latest value of the metric. The asset's resilience is based on non-cyclical demand for consumables, while stability is ensured by the critical importance of blood collection systems and syringes for global medicine.

BDX (Becton Dickinson & Co) Net Profit history from 07/04/2022 to 10/30/2026

Analytical breakdowns and data insights for company Becton Dickinson (BDX)

- market value and analyst target forecast:
Stock Price Becton Dickinson & Company|BDX - Price Target Chart
- market capitalization data:
Market Value Becton Dickinson & Company|BDX - Real Price to Acquire Entire Company
- book capitalization indicators:
Accounting Value of a Share Becton Dickinson|BDX - Book Capitalization|Market Capitalization to Book Value bd.com|BDX - Aggregate Company Assets
- debt and solvency information:
Debt to Equity Ratio Becton Dickinson & Co|BDX - Long-Term Debt to Equity|Short-Term Debt to Capital Coefficient BD|BDX - Company Total Debt|Debt to Book Capital Becton Dickinson & Company|BDX - Company Long-Term Debt|Company Short-Term Loans and Borrowings Becton Dickinson|Quick Ratio bd.com
- net income and valuation multiples indicators:
BDX - Company Net Income
Summary company analysis:Becton Dickinson & Company - BDX
Brand item of Becton, Dickinson and Company

This indicator reflects net income, serving as the final result after deducting all operating and tax expenses from revenue. The metric allows for the filtering out of market speculation, capturing the business's real cash flow. For Becton Dickinson & Co (BDX), stable income confirms its status as a leader in the production of critical medical supplies. An analysis of the company's aggregate financial result reveals resilient margins amid global confidence from clinics. The trend line helps identify structural changes in profitability in a timely manner.

Main competitors

Intuitive Corp (ISRG) - Net Profit|Company Net Income Danaher Corp.|Company Net Income STE|Net Income WST (West Pharmaceutical Services, Inc.)|BAX (Baxter International Inc.) - Final Profit|Net Profit MASI (Masimo Personal Health)|Net Financial Result Stevanato Group Corp (STVN)|TFX - Company Net Income|MMSI (merit.com) - Company Profit|Envista (NVST) - Company Net Income|ICUI - Net Financial Result|Net Income XRAY|LMAT (LeMaitre Corp) - Profit After Payment of Taxes|Company Net Income AtriCure, Inc. (ATRC)|STAA (staar.com) - Final Profit|ChromaDex Corp - Net Income|Net Profit ZimVie Inc ZIMV|ANGO - Company Net Income|Cerus Inc (CERS) - Net Income|TKNO: Net Profit|Company Net Income monogramorthopedics.com (MGRM)|Company Net Income Sharps Technology Inc|Company Profit INFU (InfuSystem Inc)|Net Income UTMD (Utah Medical)|Profit After Payment of Taxes KRMD|Company Net Income Nyxoah S.A. NYXH|Net Financial Result microbotmedical.com (MBOT)|Pro-Dex - Net Profit|ZTEK: Company Net Income|ELUT: Net Profit|Company Net Income Milestone Scientific Corporation (MLSS)|NXGL (NEXGEL, Inc.) - Net Profit|Net Income Retractable Tech (RVP)|Net Income HBIO (Harvard Bioscience, Inc.)|Profit After Payment of Taxes FEMY|Company Net Income Meihua Medical Technologies Co., Ltd. MHUA|Predictive Oncology Inc (POAI) - Company Net Income|CJMB - Company Net Income|ATRI (atrioncorp.com) - Company Profit|NURO (NeuroMetrix) - Net Income